Luminex logo

LMNX - Luminex News Story

$36.91 0.0  0.1%

Last Trade - 9:00pm

Sector
Healthcare
Size
Mid Cap
Market Cap £1.23bn
Enterprise Value £1.15bn
Revenue £300.2m
Position in Universe 2379th / 6849

BRIEF-Luminex Corp Reports Fourth Quarter And Full-Year 2019 Results

Mon 10th February, 2020 10:11pm
Feb 10 (Reuters) - Luminex Corp  LMNX.O :
    * ORATION REPORTS FOURTH QUARTER AND FULL-YEAR 2019 RESULTS
    * Q4 REVENUE $90.5 MILLION VERSUS REFINITIV IBES ESTIMATE OF
$90.6
MILLION
    * SEES Q1 2020 REVENUE $82 MILLION TO $84 MILLION
    * SEES FY 2020 REVENUE $352 MILLION TO $362 MILLION
    * Q1 REVENUE VIEW $87.8 MILLION -- REFINITIV IBES DATA
    * FY2020 REVENUE VIEW $357.0 MILLION -- REFINITIV IBES DATA
    * QTRLY EARNINGS PER SHARE $0.07
    * Q4 EARNINGS PER SHARE VIEW $-0.01 -- REFINITIV IBES DATA
    * EXPECT TO SUBMIT VERIGENE II RESPIRATORY FLEX ASSAY TO FDA
IN Q1
OF 2020

Source text for Eikon:  ID:nPn8yw8fTa 
Further company coverage:  LMNX.O 

 ((Reuters.Briefs@thomsonreuters.com;))
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.